TY - JOUR
T1 - How patient, infection, and cysticercus characteristics impact the evolution of Taenia solium larva in the human brain
T2 - A unique cyst-level analysis
AU - Zhang, Hongbin
AU - Shamsunder, Meghana G.
AU - Bawa, Pryanka
AU - Carpio Rodas, Luis Arturo
AU - Hauser, Willard Allen
AU - Quinde Herrera, Karina Sandra
AU - Jaramillo, Alexander
AU - Kelvin, Elizabeth A.
N1 - Publisher Copyright:
© 2025 Cambridge University Press. All rights reserved.
PY - 2025
Y1 - 2025
N2 - Neurocysticercosis is a poorly understood infection of the central nervous system with Taenia solium larva and treatment often fails to kill all the parasitic larva. Most research on this infection has used patient-level data, looking at summaries of the encysted parasitic cysticercus burden. Cyst-level analysis is needed to identify factors that impact individual cyst trajectories and how that may vary based on characteristics of the patient, infection, and cyst being followed. We disaggregated data on 221 cysts from 117 patients who participated in a trial evaluating the impact of albendazole treatment to identify factors that impact cyst evolution over time from the active to the degenerating and calcified phases, and eventual resolution. We found that having calcified cysts at baseline was associated with a faster rate of transition from the degenerative phase to calcified or resolution. Age and sex were not associated with cyst evolution in the main effect analysis but after stratifying on treatment we found that the direction of some associations by patient age and sex were reversed for patients in the albendazole arm compared to those in the placebo arm. These findings suggest that that differences in host immune response by sex and age as well as by past exposure, potentially indicated by having calcified cysts together with active cysts at baseline, are important to cyst evolution and may be modified by treatment. Future research is needed to assess if these differences suggest distinct treatment recommendation
AB - Neurocysticercosis is a poorly understood infection of the central nervous system with Taenia solium larva and treatment often fails to kill all the parasitic larva. Most research on this infection has used patient-level data, looking at summaries of the encysted parasitic cysticercus burden. Cyst-level analysis is needed to identify factors that impact individual cyst trajectories and how that may vary based on characteristics of the patient, infection, and cyst being followed. We disaggregated data on 221 cysts from 117 patients who participated in a trial evaluating the impact of albendazole treatment to identify factors that impact cyst evolution over time from the active to the degenerating and calcified phases, and eventual resolution. We found that having calcified cysts at baseline was associated with a faster rate of transition from the degenerative phase to calcified or resolution. Age and sex were not associated with cyst evolution in the main effect analysis but after stratifying on treatment we found that the direction of some associations by patient age and sex were reversed for patients in the albendazole arm compared to those in the placebo arm. These findings suggest that that differences in host immune response by sex and age as well as by past exposure, potentially indicated by having calcified cysts together with active cysts at baseline, are important to cyst evolution and may be modified by treatment. Future research is needed to assess if these differences suggest distinct treatment recommendation
KW - albendazole
KW - Ecuador
KW - multistate modeling
KW - Neurocysticercosis
KW - Taenia solium
KW - Albendazol
KW - Ecuador
KW - Neurocistercosis
KW - Taenia solium
KW - Albendazole
KW - Multistate modeling
KW - Neurocysticercosis
UR - https://www.scopus.com/pages/publications/85216745388
UR - https://www.cambridge.org/core/journals/parasitology/article/how-patient-infection-and-cysticercus-characteristics-impact-the-evolution-of-taenia-solium-larva-in-the-human-brain-a-unique-cystlevel-analysis/BAEA1770AB4F2AEB09E1A80FFCA937A5
U2 - 10.1017/S003118202400163X
DO - 10.1017/S003118202400163X
M3 - Artículo
C2 - 39851070
AN - SCOPUS:85216745388
SN - 0031-1820
VL - 0
SP - 1
EP - 12
JO - Parasitology
JF - Parasitology
IS - 0
ER -